PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trialZehua Wu, Yanhong Deng, Lishuo Shi et al.|Med|2024Cited by 16
Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trialYi Cheng, Yanhong Deng, Zehua Wu et al.|EClinicalMedicine|2022Cited by 15
Distinct Clinicopathological Features and Prognostic Values of High-, Low-, or Non-Expressing HER2 Status in Colorectal CancerZehua Wu, Yanhong Deng, Yi Cheng et al.|Cancers|2023Cited by 6